The Misuse of Drugs Act 1971 (Amendment) Order 2018
Draft 2018, ISBN 9780111173510
Draft Order laid before Parliament under section 2(5) of the Misuse of Drugs Act 1971, for approval by resolution of each House of Parliament.
Dangerous Drugs
Made ** 2018
Coming into force 1st April 2019
At the Court at **, the **
Present,
The Queen’s Most Excellent Majesty in Council
In accordance with section 2(5) of the Misuse of Drugs Act 1971f1 a draft of this Order has been laid before Parliament on the recommendation of the Advisory Council on the Misuse of Drugs and approved by a resolution of each House of Parliament.
Accordingly, Her Majesty, in exercise of the powers conferred upon Her by section 2(2) of that Act, is pleased, by and with the advice of Her Privy Council, to order as follows:
Annotations to the whole text
Footnotes
- f1
-
1971 c. 38. Schedule 2 has been amended by section 21 of the Drugs Act 2005 (c. 17) and S.I. 1973/771, 1975/421, 1977/1243, 1979/299, 1983/765, 1984/859, 1985/1995, 1986/2230, 1989/1340, 1990/2589, 1995/1966, 1996/1300, 1998/750, 2001/3932, 2003/1243, 2003/3201, 2005/3178, 2006/3331, 2008/3130, 2009/3209, 2010/1207, 2010/1833, 2011/744, 2012/1390, 2013/239, 2014/1106, 2014/1352, 2014/3271, 2015/215, 2016/1109, 2017/634 and 2017/1114.
Contents
1Citation and commencement
This Order may be cited as the Misuse of Drugs Act 1971 (Amendment) Order 2018 and comes into force on the 1st April 2019.
2Amendments to the Misuse of Drugs Act 1971
The following amendments are made to Schedule 2 to the Misuse of Drugs Act 1971.
In paragraph 1(b) of Part 3 (which specifies the drugs which are subject to control under that Act as Class C drugs)—
after “Furazabol.” insert—
“Gabapentin (1-(aminomethyl)cyclohexaneacetic acid).”, and
after “Prasterone.” insert—
“Pregabalin ((S)-3-(aminomethyl)-5-methylhexanoic acid).”.
Signature
Name
Clerk of the Privy Council
Explanatory note
(This note is not part of the Order)
This Order brings certain drugs under the control of the Misuse of Drugs Act 1971. Article 2(2) of this Order brings the compounds known as Pregabalin and Gabapentin under permanent control as Class C drugs under that Act.
A full impact assessment of the effect that this instrument will have on the costs of business, the voluntary sector and the public sector is available at https://legislation.gov.uk.